The pharmaceutical company shared that when they compared the two sets of groups, comprising 1,500 males - one was given placebo, the other was taking the clascoterone. In the first trial, the drug showcased an improvement of 539%. In another trial, the recorded improvement was at 168%.

As far as the side effects are concerned, the company said they found clascoterone to be safe and tolerable. "With strong efficacy across the two largest Phase III studies, and a favourable safety profile, clascoterone 5% topical solution opens the door to a fundamentally better treatment paradigm for patients," said Giovanni Di Napoli, Cosmo CEO, in a statement from the company.

https://www.ndtv.com/lifestyle/scientists-find-cure-for-male-pattern-baldness-in-acne-drug-approved-5-years-ago-9770093/amp/1